Cited by 183Cancer, Hypoxia, and MetabolismCancer Immunotherapy and BiomarkersCytokine Signaling Pathways and Interactions

The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis

Open access
Noman, Muhammad Zaeem, Buart, Stéphanie, Van Pelt, Jos, Richon, Catherine, Hasmim, Meriem, Leleu, Nathalie, Suchorska, Wictoria Maria, Jalil, Abdelali +9 more·2009·The Journal of Immunology

Abstract

Hypoxia is an essential component of tumor microenvironment. In this study, we investigated the influence of hypoxia (1% PO2) on CTL-mediated tumor cell lysis. We demonstrate that exposure of target tumor cells to hypoxia has an inhibitory effect on the CTL clone (Heu171)-induced autologous target cell lysis. Such inhibition correlates with hypoxia-inducible factor-1α (HIF-1α) induction but is not associated with an alteration of CTL reactivity as revealed by granzyme B polarization or morphological change. Western blot analysis indicates that although hypoxia had no effect on p53 accumulation, it induced the phosphorylation of STAT3 in tumor cells by a mechanism at least in part involving vascular endothelial growth factor secretion. We additionally show that a simultaneous nuclear translocation of HIF-1α and phospho-STAT3 was observed. Interestingly, gene silencing of STAT3 by small interfering RNA resulted in HIF-1α inhibition and a significant restoration of target cell susceptibility to CTL-induced killing under hypoxic conditions by a mechanism involving at least in part down-regulation of AKT phosphorylation. Moreover, knockdown of HIF-1α resulted in the restoration of target cell lysis under hypoxic conditions. This was further supported by DNA microarray analysis where STAT3 inhibition resulted in a partly reversal of the hypoxia-induced gene expression profile. The present study demonstrates that the concomitant hypoxic induction of phopho-STAT3 and HIF-1α are functionally linked to the alteration of non-small cell lung carcinoma target susceptibility to CTL-mediated killing. Considering the eminent functions of STAT3 and HIF-1α in the tumor microenvironment, their targeting may represent novel strategies for immunotherapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.0800854

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Normoxic and hypoxic stabilization of HIF signaling in tumor cells promotes resistance to cytotoxic T lymphocyte-mediated lysis.

    “Normoxic and hypoxic stabilization of HIF signaling in tumor cells promotes resistance to cytotoxic T lymphocyte–mediated lysis”

    From Hypoxic control of metastasis (2016) · cites this paper as [52]

  • Hypoxic tumor cells have increased resistance to CTL-mediated lysis, correlated with hypoxic induction of tumor cell autophagy.

    “the increased resistance of hypoxic tumor cells to CTL-mediated lysis. This increased resistance to CD8 T cell-mediated killing is correlated with the hypoxic induction of tumor cell autophagy [86, 87].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 55 · Cited by 183

Authors
Noman, M. Z., Buart, S., Van Pelt, J., Richon, C., Hasmim, M., Leleu, N., Suchorska, W. M., Jalil, A., Lecluse, Y., El Hage, F., Giuliani, M., Pichon, C., Azzarone, B., Mazure, N., Romero, P., Mami-Chouaib, F., & Chouaib, S.
Affiliations
  • Inserm (FR)
  • Department of Hepatology, University Hospital Gasthuisberg , Leuven,
  • Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 753, Villejuif,
  • Institut Gustave Roussy PR2 , Villejuif,
  • Centre National de la Recherche Scientifique (FR)
  • Ludwig Cancer Research (BE)
Corresponding author
  • Richon, Catherine
  • Hasmim, Meriem
  • Leleu, Nathalie
  • Jalil, Abdelali
  • Pichon, Christophe
Venue
The Journal of Immunology
Published
2009-03
Volume
182
Issue
6
Pages
3510-3521
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1799143857
Cited by
183
References
55
Citations by year
2025: 5 · 2024: 4 · 2023: 18 · 2022: 5 · 2021: 18 · 2020: 17 · 2019: 8 · 2018: 14 · 2017: 12 · 2016: 13 · 2015: 13 · 2014: 19 · 2013: 15 · 2012: 11
FWCI
2.43
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • Association pour la Recherche sur le Cancer
  • European Bioinformatics Institute
  • Agence Nationale de la Recherche
  • Ligue Contre le Cancer
  • Institut National Du Cancer
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
Keywords
hypoxia, hypoxia-inducible factor-1α, STAT3 phosphorylation, tumor microenvironment, non-small cell lung cancer, vascular endothelial growth factor, Akt phosphorylation, p53, tumor immunosuppression, HIF-1α nuclear translocation, cancer immunotherapy
MeSH terms
Hypoxia, Clone Cells, Cytotoxicity, Immunologic, Humans, Immunity, Innate, Lung Neoplasms, T-Lymphocytes, Cytotoxic, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, STAT3 Transcription Factor, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review